Current News

NICE recommends CardioQ-ODM for Invasive Cardiac Monitoring

PEI recently published a news item discussing the National Institute for Health and Clinical Excellence’s (NICE) recommendation that CardioQ-ODM be considered for use in patients undergoing major or high-risk surgery. It is worth noting that NICE also recommended the use of CardioQ-ODM in other instances where cardiac monitoring may be considered. In a report published in March this year, entitled CardioQ-ODM Oesophageal Doppler Monitor (which can be downloaded on the right), NICE stated:


“The Committee concluded that the available data support a clinical benefit and a cost saving when the CardioQ-ODM is used in patients undergoing major or high-risk surgery or other surgical patients in whom a clinician would consider using invasive cardiac monitoring”.


The same report also highlighted the main benefits of using the CardioQ-ODM, which include a reduction in the following:  


post-operative complications; 

use of central venous catheters; 

hospital stays; 

re-admission rates 


The benefits imply a significant cost saving per patient for healthcare providers. 


Therefore, considering NICE’s evidence it is apparent that there are significant benefits to be gained from using the CardioQ-ODM for invasive cardiac monitoring.


If you would like further information on CardioQ-ODM please contact your local hospital representative, or call us directly on +353 1 419 6900. There are also a number of resources that can be accessed in the menu on the right.

February 2020
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 1
2 3 4 5 6 7 8

External Links